← Evidence map

ArticleInvestigational new drugs2021

A novel LRRFIP1-ALK fusion in inflammatory myofibroblastic tumor of hip and response to crizotinib.

Weifeng Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2021
2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32915420